Issues related to the regulation of medical devices.
Issues related to maternal morbidity and mortality.
Issues related to medical device sterilization and supply chain impact of EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Coverage of in-office tympanostomy tubes.
Duration: June 1, 2015
to
present
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Taxation/Internal Revenue Code , Government Issues
Spending: about $1,760,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office
Related Foreign Entities:
Smith & Nephew Management B.V. (Hoofddorp, NED); contribution to lobbying: $0; ownership 100%; Smith & Nephew USD Limited (London, GBR); contribution to lobbying: $0; ownership 100%; TP Limited (Edinburgh, GBR); contribution to lobbying: $0; ownership 100%; Smith & Nephew (Overseas) Limited (London, GBR); contribution to lobbying: $0; ownership 100%; Smith & Nephew PLC (London, GBR); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jane Loewenson Health Fellow, Sen. George Mitchell, Prof. Staff Member, Subcomm. on Children and Families of the Sen. Labor and Human Resources Committee; Sen. Chris Dodd, Sr Health Policy Advisor; Sen. Thomas Daschle, Sr Health Policy Advisor
Lisa Foster Sen. Jack Reed, Sr. Policy Advisor
Bonnie Duffy Senior Policy Advisor - Senate Democratic Policy Committee; Legislative Assistant - Sen. Jack Reed; Professional Staff - Senate Special Committee on Aging
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 22.
Original Filing: 301572680.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Issues related to maternal morbidity and mortality.
Issues related to medical device sterilization and supply chain impact of EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Coverage of in-office tympanostomy tubes.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301537583.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Issues related to maternal morbidity and mortality.
Issues related to medical device sterilization and supply chain impact of EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Coverage of in-office tympanostomy tubes.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301511761.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Issues related to medical device supply chain.
Issues related to medical device sterilization and supply chain impact of EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
Coverage of in-office tympanostomy tubes.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301491170.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Issues related to medical device supply chain.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
Coverage of in-office tympanostomy tubes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pressure Injury prevention guidelines at the VA.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301459825.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
Coverage of in-office tympanostomy tubes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pressure Injury prevention guidelines at the VA.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 20, 2023.
Original Filing: 301439175.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Issues related to shortage reporting.
Issues related to risk mitigation.
P.L. 117-328 Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
H.R.2356/S.2363 - Better Wound Care at Home Act in the P.L. 117-328 Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301412732.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Reauthorization of the Medical Device User Fee Act.
Issues related to shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
H.R.2356/S.2363 - Better Wound Care at Home Act.
CY 2023 Physician Fee Schedule proposed changes to reimbursement for skin substitutes.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301395229.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Reauthorization of the Medical Device User Fee Act.
Issues related to shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
H.R.2356/S.2363 - Better Wound Care at Home Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301368704.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Reauthorization of the Medical Device User Fee Act.
Issues related to shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
H.R.2356/S.2363 - Better Wound Care at Home Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provisions related to interest expense limitations under IRC section 163(j) and proposed section 163(n) in H.R.5376 - Build Back Better Act.
Provisions related to the Base Erosion and Anti-Abuse Tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2021
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301335892.xml
Lobbying Issues
Issues related to the regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
Better Wound Care at Home Act (H.R. 2356/S. 2363).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provisions related to interest expense limitations under IRC section 163(j) and proposed section 163(n) in the Build Back Better Act (H.R. 5376);
Provisions related to the Base Erosion and Anti-Abuse Tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2021
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301310173.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
Better Wound Care at Home Act (H.R. 2356/S. 2363).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provisions related to interest expense limitations under IRC section 163(j) and proposed section 163(n) in H.R. 5376;
Provisions related to the Base Erosion and Anti-Abuse Tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2021
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301284493.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
H.R. 2356, to amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301260139.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
H.R. 2356, to amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 21, 2021.
Original Filing: 301244301.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
H.R. 7127, to amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices;
S. 4295, Public Health Emergency Pass-through Payment Fairness Act of 2020;
H.R. 8624, the Protecting Access to Innovation During COVID-19 Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 19, 2020.
Original Filing: 301215460.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
H.R. 7127, to amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices;
S. 4295, Public Health Emergency Pass-through Payment Fairness Act of 2020.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $40,000. The report was filed on July 20, 2020.
Original Filing: 301195871.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy;
H.R. 7127, to amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301177327.xml
Lobbying Issues
Issues related to regulation of medical devices;
Medical device issues in the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019 (H.R. 2113).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable negative pressure wound therapy.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 21, 2020.
Original Filing: 301126842.xml
Lobbying Issues
Issues related to regulation of medical devices; medical device issues in the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019 (H.R. 2113).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax;
Protect Medical Innovation Act of 2019 (S.692/H.R.2207);
Further Consolidated Appropriations Act, 2020 (H.R. 1865).
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Foreign Agents Registration Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable durable medical equipment.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066741.xml
Lobbying Issues
Issues related to regulation of medical devices; medical device issues in the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019 (H.R. 2113).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Foreign Agents Registration Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable durable medical equipment.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 16, 2019.
Original Filing: 301046800.xml
Lobbying Issues
Issues related to regulation of medical devices; medical device issues in the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019 (H.R. 2113).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Foreign Agents Registration Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable durable medical equipment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 18, 2019.
Original Filing: 301029370.xml
Lobbying Issues
Issues related to regulation of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Foreign Agents Registration Act in H.R.1.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of coverage for disposable durable medical equipment.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009465.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Issues related to third party servicing of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to S.2039 - Disclosing Foreign Agents Act and H.R.4170 - Disclosing Foreign Agents Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare 2019 Hospital Outpatient prospective payment system (related to payment for skin substitute) proposed rule.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 18, 2018.
Original Filing: 300988798.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Issues related to third party servicing of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to S.2039 - Disclosing Foreign Agents Act and H.R.4170 - Disclosing Foreign Agents Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare 2019 Hospital Outpatient prospective payment system (related to payment for skin substitute) proposed rule.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2018.
Original Filing: 300978036.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers;
Issues related to third party servicing of medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to S.2039 - Disclosing Foreign Agents Act and H.R.4170 - Disclosing Foreign Agents Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2018.
Original Filing: 300956271.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936870.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical device tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2017.
Original Filing: 300916571.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2017.
Original Filing: 300895796.xml
Lobbying Issues
Issues related to regulation of medical devices, post-market surveillance of medical devices and unique device identifiers.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2017.
Original Filing: 300877669.xml
Lobbying Issues
Issues related to post-market surveillance of medical devices and unique device identifiers.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857244.xml
Lobbying Issues
Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, the FY 2016 omnibus appropriations and tax extenders legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to post-market surveillance of medical devices and unique device identifiers
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2016.
Original Filing: 300838818.xml
Lobbying Issues
Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, the FY 2016 omnibus appropriations and tax extenders legislation;
Issues related to unique device identifiers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to post market surveillance of medical devices and unique device identifiers (UDIs)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2016.
Original Filing: 300820544.xml
Lobbying Issues
Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, the FY 2016 omnibus appropriations and tax extenders legislation;
Issues related to unique device identifiers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to post market surveillance of medical devices and unique device identifiers (UDIs)
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300802778.xml
Lobbying Issues
Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, the FY 2016 omnibus appropriations and tax extenders legislation
Lobbying Issues
Issues related to post market surveillance of medical devices and unique device identifiers (UDIs)
4th Quarter, 2015
In Q4, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 20, 2016.
Original Filing: 300783063.xml
Lobbying Issues
Disposable medical technologies;
H.R. 6, 21st Century Cures Act;
S. 1253, Patient Access to Disposable Medical Technology Act of 2015;
Proposed 2016 Hospital Outpatient Payment Rule
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764135.xml
Lobbying Issues
Provisions related to disposable medical technologies in the 21st Century Cures Act (H.R. 6) and the Patient Access to Disposable Medical Technology Act of 2015 (S. 1253); proposed 2016 Hospital Outpatient Payment Rule
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, NVG, LLC lobbied for Smith & Nephew, Inc. , earning $20,000. The report was filed on July 20, 2015.
Original Filing: 300743634.xml
Lobbying Issues
Provisions related to disposable medical technologies in the 21st Century Cures Act (H.R. 6) and the Patient Access to Disposable Medical Technology Act of 2015 (S. 1253)
Agencies Lobbied
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...